Form 4 for MRNA Moderna
Accepted 2021-07-02 00:00:00 ET · period of report 2021-06-30 · accession 0001127602-21-021250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-02 | 2021-06-30 | MRNA | Zaks Tal Zvi | Chief Medical Off | S - Sale+OE | $237.00 | -5,000 | 0 | -100% | -$1.19M |
| D | 2021-07-02 | 2021-06-30 | MRNA | Zaks Tal Zvi | Chief Medical Off | M - OptEx | $25.93 | +5,000 | 5,000 | New | +$129.7K |
| D | 2021-07-02 | 2021-06-30 | MRNA | Zaks Tal Zvi | Chief Medical Off | M - OptEx | $0.00 | -5,000 | 121.1K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-30 | S | D | 5,000 | $237.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-06-30 | M | A | 5,000 | $25.93 | 5,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-06-30 | M | D | 5,000 | $0.00 | 121,120 | D | $25.93 · — to 2030-02-28 | 5,000 Common Stock | (F2) 25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |